{
    "clinical_study": {
        "@rank": "149609", 
        "acronym": "COOL-ARREST", 
        "arm_group": {
            "arm_group_label": "Induced therapeutic hypothermia", 
            "arm_group_type": "Experimental", 
            "description": "Induced therapeutic hypothermia post cardiac arrest"
        }, 
        "brief_summary": {
            "textblock": "A multicenter prospective single arm interventional trial in hospitals where therapeutic\n      hypothermia is standard practice.  This trial will enroll 50 subjects to evaluate the\n      ability of the ZOLL Intravascular Temperature Management (IVTM) System to induce, maintain,\n      and reverse mild therapeutic hypothermia and maintain normothermia post cardiac arrest."
        }, 
        "brief_title": "COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest", 
        "condition": "Out of Hospital Cardiac Arrest", 
        "condition_browse": {
            "mesh_term": [
                "Heart Arrest", 
                "Out-of-Hospital Cardiac Arrest"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed Informed Consent\n\n          -  18 years of age or older\n\n          -  Out-of-hospital witnessed arrest or unwitnessed arrest\n\n          -  Return to spontaneous circulation within 30 min of EMS arrival\n\n        Exclusion Criteria:\n\n          -  Traumatic cardiac arrest\n\n          -  Toxicological etiology\n\n          -  known or suspected pregnancy\n\n          -  Do Not Attempt to Resuscitate order in force\n\n          -  Ward of the state or prisoner\n\n          -  Anatomy, previous surgery or disease state contraindicating femoral venous access\n\n          -  Hypothermia initiated at a transferring facility prior to arrival at the enrolling\n             hospital\n\n          -  History of acute neurological illness or severe functional disabilities prior to\n             arrest\n\n          -  Known history of bleeding or blood disorders\n\n          -  History of Raynaud's disease\n\n          -  Evidence of intracranial bleed\n\n          -  Terminal illness of life expectancy of less than 3 months\n\n          -  Currently enrolled in another investigational drug or device trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01818388", 
            "org_study_id": "EDC-1978"
        }, 
        "intervention": {
            "arm_group_label": "Induced therapeutic hypothermia", 
            "description": "Induced therapeutic hypothermia post cardiac arrest", 
            "intervention_name": "ZOLL Intravascular Temperature Management System (IVTM)", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "March 21, 2013", 
        "number_of_arms": "1", 
        "official_title": "A Multicenter, Prospective, Single Arm Interventional Trial to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest", 
        "overall_contact": {
            "email": "rkochevar@zollcirculation.com", 
            "last_name": "Renee Kochevar, PhD, ALM", 
            "phone": "408-419-2904"
        }, 
        "overall_official": {
            "affiliation": "Wayne State University, School of Medicine  Specialist and Chief, Detroit Medical Center", 
            "last_name": "Brian O'Neil, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Proportion of subjects in which IVTM can therapeutically cool patients as a measure of Performance", 
            "safety_issue": "No", 
            "time_frame": "Day 1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01818388"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Ability to Enroll Suubjects, Proportion of those Enrolled that Complete the Study Protocol and Time to complete Enrollment of 50 Subjects Defined as Retention", 
                "safety_issue": "No", 
                "time_frame": "Up to 90 days"
            }, 
            {
                "measure": "Incident Adverse Events Defined as Safety", 
                "safety_issue": "Yes", 
                "time_frame": "Up  to 90 days"
            }
        ], 
        "source": "ZOLL Circulation, Inc., USA", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ZOLL Circulation, Inc., USA", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}